1. Dubé, E. Laberge, C. Guay, M. Bramadat,P. Roy, R. Bettinger, A. (2019): Vaccine hesitancy: An overview. Hum Vaccin Immunother2019 Aug;9(8):1763-1773 [FREE Full text] [doi: 10.4161/hv.24657] [Medline: 23584253].
2. Schaffer DeRoo S. Pudalov N. Fu L. (2020): Planning for a COVID-19 vaccination program. JAMA 2020 Jun 23;323(24):2458-2459. [doi: 10.1001/jama.2020.8711] [Medline: 32421155].
3. WHO, World Health Organization, (2021): COVAX Announces Additional Deals to Access Promising COVID-19 Vaccine Candidates; Plans Global Rollout Starting Q1 2021.
4. Lazarus, J. Ratzan, S.Palayew, A. Gostin, L. Larson, H. Rabin, K. Kimball, S. El-Mohandes, A. (2020): A global survey of potential acceptance of a COVID-19 vaccine. Nat. Med. 2020, 27, 225–228.
5. Qattan, A. Al shareef, N. Al sharqi, O. Al Rahahleh, N. Chirw, G. Al-Hanawi, M. (2021): Acceptability of a COVID-19 Vaccine Among Healthcare Workers in the Kingdom of Saudi Arabia. Front. Med. 2021, 8, 644300.
6. Al Fageeh, E. Al Shareef, N., Kasttab, N. Alhazmi, F. Chirw, C. (2021): Acceptability of a COVID-19 Vaccine among the Saudi Population; Vaccines 2021, 9, 226.
7. Fakhroo, A. Al Thani, A. Yassine, H. (2020): Markers associated with COVID-19 susceptibility, resistance, and severity. Viruses. 2020;13(1):45. doi:10.3390/
v13010045
8. Alhalaseh, L., Fayoumi, H., Khalil, B., (2020): The health belief model in predicting
healthcare workers’ intention for influenza vaccine uptake in Jordan. Vaccine 38
(46), 7372–7378.
9. Al Kaabi, N. Zhang, Y. Xiaoming, S Yang, Y. Al Qahtani, M. Abdulrazzaq, N. Al Nusair, M. Hassany, M. Jawad, J. Abdalla, J. Hussein, S. Al Mazrouei, S. Al Karam, M. Li, X. Yang, X. Wang, W. Lai, B. Chen, W. Huang, S. Wang, Q. et al., (2021): Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults. JAMA. 2021; 326(1):35-45. doi:10.1001/jama.2021.8565
Published online May 26, 2021.
10. Barry, M., Temsah, M.-H., Alhuzaimi, A., Alamro, N., Al-Eyadhy, A., Aljamaan, F., et al., (2020): COVID-19 vaccine confidence and hesitancy among healthcare workers: across-sectional survey from a MERS-CoV experienced nation. medRxiv
11. Brunon, A. Detoc, M. Bruel, S. Tardy, B., Rozaire, O. Frappe, P., et al., (2020): Intention to get vaccinations against COVID-19 in French healthcare workers during the first pandemic wave: a cross sectional survey. J. Hosp. Infect. 108, 168–173.
https://doi.org/10.1016/j.jhin.2020.11.020.
12. Detoc, M. Bruel, S. Frappe, P. Tardy, B. Botelho-Nevers, E. & Gagneux-Brunon, A. (2020): Intention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemic. Vaccine 38 (45), 7002–7006.
13. Lopez, J. Andrews, N. Gower, C. (2021): Early effectiveness of COVID-19 vaccination with vaccines and symptomatic disease, hospitalizations and mortality in England. Med-Rxiv 2021; 46: 342–47
14. Mahmud, I. Kabir, R. Aziz Rahman, M. Mohamed, A. Vinnakota, D. and Al-Mohaimeed, A. (2021): The Health Belief Model Predicts Intention to Receive the COVID-19 Vaccine in Saudi Arabia. Vaccines; 2021, 9, 864. https://doi.org/10.3390/ vaccines9080864
15. Malik, A. McFadden, S. El harake, J. & Omer, S. (2020): Determinants of COVID-19 vaccine manifestation and outcome in the US. EClinical Medicine 26, 100495
(2020).
16. Maraqa, M. Nazzal, Z. Rabi c, R. Sarhan, N. Al-Shakhra, K. Al-Kaila, M. (2021): COVID-19 vaccine hesitancy among health care workers in Palestine: A call for action; Preventive Medicine 149 (2021) 106618; www.elsevier.com/locate/ypmed
17. Menni C, Valdes AM, Freidin MB, et al. (2020): Real-time tracking of self-reported symptoms and diseases to predict potential COVID-19. Nat Med 2020; 26: 1037–40.
18. Menni, C. Klaser, K. May, A. Polidori, L. Capdevila, Panayiotis Louca, Sudre, C. Nguyen, L. Drew, D. Merino, J. Hu, C. Selvachandran, S. Antonelli, M. Murray, B. Canas, L. Molteni, E. et al., (2021): Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study. Lancet Infect Dis 2021; 21: 939–49 Published Online April 27, 2021 https://doi.org/10.1016/ S1473-3099 (21)00224-3
www.thelancet.com/infection Vol 21 July 2021
19. Nazzal, Z. Rabi, R. Sarhan,R. Al-Shakhra, K. Al-Kaila, M. (2021): COVID-19 vaccine hesitancy among health care workers in Palestine: A call for action. Preventive Medicine 149 (2021) 106618 www.elsevier.com/locate/ypmed
20. Nazzal, Z., Dmaidi, L., Hamshari, Y., (2015): Influenza vaccine uptake among Palestinian Hospitals’ health care workers: barriers and motivators. Jacobs J. Commun. Med. 1(2), 2–7.
21. Polack FP, Thomas SJ, Kitchin N, et al. (2020): Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. N Engl J Med 2020; 383: 2603–15.
22. Rappuoli, R. Mandl, C. Black, S. De Gregorio, E. (2018): Vaccines for the twenty-first century society. Nat Rev Immunol 2018Nov 04;11(12):865-872 [FREE Full text] [doi: 10.1038/nri3085] [Medline: 22051890]
23. Roozenbeek, J. Schneider, C. Dryhurst, S. Kerr, J. Freeman, A. Recchia, G. van der Bles, A. van der Linden, S. (2020): Susceptibility to misinformation about COVID-19 around the world. R. Soc. Open Sci. 2020,7, 201199.
24. Saadat S, Rikhtegaran-Tehrani Z, Logue J, et al. (2021): Single dose vaccination in healthcare workers previously infected with SARS-CoV-2. medRxiv 2021; published online Feb 1. https://doi.org/10.1101/2021.01.30.21250843
25. Tran, V. Pak, T. Gribkova, E. Galkina, G. Loskutova, E. Dorofe, V. Dewey, R. Nguyen, K.Pham, D. (2021): Determinants of COVID-19 vaccine acceptance in a high infection-rate country: A cross-sectional study in Russia. Pharm. Pract. 2021, 19, 2276.
26. Twohig, K. Nyberg, T. Thelwall, S. & Aliabaadi, S. (2021): Hospital admission and emergency care attendance risk for SARS-CoV-2 delta compared with alpha variants of concern. Infectious diseases; 4:11
27. Voysey, M. Clemens, S. Madhi, S. Weckx, L. Folegatti, P. Aley, P. et al., (2020): Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet 8(23)
28. Wise J. (2021): COVID-19: people who have had infection might only need one dose of vaccine. BMJ 2021; 372: n308.
29. Wong, M. Wong, E. Huang, J. Cheung, A. Law, K. Chong, M. Lai, C. Boon, S. Lau, J. et al. (2021): Acceptance of the COVID-19 vaccine based on the health belief model: A population-based survey in Hong Kong. Vaccine 2021, 39, 1148–1156.
30. Xia S. Duan K. Zhang Y. et al. (2020): Effect of an inactivated vaccine against SARS-CoV-2 on safety and immunogenicity outcomes: interim analysis of 2 randomized clinical trials. JAMA. 2020; 324(10): 951-960. doi:10.1001/jama.2020.15543